ArticleAging2022

CXCR4 knockdown enhances sensitivity of paclitaxel via the PI3K/Akt/mTOR pathway in ovarian carcinoma.

Dan Zi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.